CBN Approves Over 10 Billiona Naira for Health Intervention


The Central Bank of Nigeria (CBN) has said that over N10 billion loans and grants have been approved for various groups and organisations for pharmaceutical and healthcare-related research, under the COVID-19 intervention scheme.

Confirming this in Abuja on Sunday, the spokesperson of the CBN, Isaac Okorafor, said that several other applications were also being processed, pending approval.

Okorafor said the applications covered the two broad categories under the COVID-19 intervention programmes in the healthcare sector.

His reaction followed criticisms by some groups that apex bank and the Presidential Task Force on COVID-19 was not disbursing the funds to applicants

Okorafor said:

Anyone castigating the CBN and the PTF for the grant component is just being mischievous.

Grants are guided by procedures and not a free for all. The grants and loans have to be applied for and processed. There are guidelines which must be followed.

There are qualifications for grants, and they have to be met, which in this case must include authentication by relevant government agencies such as the Nigerian Institute of Pharmaceutical Research and Development and the National Agency for Food and Drug Administration and Control (NAFDAC) on the scientific foundation of such research.

Okoroafor also stated that even where grants may be seen as free, they are not just handed out to anyone who stretches out their hands.

He said:

Applicants must have a plan detailing demonstrable and genuine scientific efforts, intentions, and above all, accompanied by a formal application requesting for the loan.

Okorafor said further that the CBN would not be discouraged from following the right procedures in the disbursement of the loans, noting that he suspected those behind the criticism to be some persons who have no regard for due process.

He, however, advised those interested in the facilities to follow the due process and submit applications for the grant and stop using the media to ridicule the good intentions of the regulatory body.

Leave a reply

Your email address will not be published.